These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20662445)

  • 1. [Prolonged prophylaxis of thromboembolic disease in patients with colorectal surgical resections for malignancy].
    Brzezková R; Frýba V; Chrz K; Krska Z; Kvasnicka J
    Rozhl Chir; 2009 Nov; 88(11):642-8. PubMed ID: 20662445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of extended preoperative thromboprophylaxis with dalteparin in patients with ovarian cancer qualified to surgical treatment.
    Krasiński Z; Szpurek D; Staniszewski R; Dzieciuchowicz L; Pawlaczyk K; Krasińska B; Wójcicka K; Urbanek T
    Int Angiol; 2014 Aug; 33(4):365-71. PubMed ID: 25056168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery.
    Magee CJ; Barry J; Javed S; Macadam R; Kerrigan D
    Surg Obes Relat Dis; 2010; 6(3):322-5. PubMed ID: 20510295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.
    Dranitsaris G; Stumpo C; Smith R; Bartle W
    Am J Cardiovasc Drugs; 2009; 9(1):45-58. PubMed ID: 19178131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
    Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
    J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study.
    Rasmussen MS; Jorgensen LN; Wille-Jørgensen P; Nielsen JD; Horn A; Mohn AC; Sømod L; Olsen B;
    J Thromb Haemost; 2006 Nov; 4(11):2384-90. PubMed ID: 16881934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism prevention in patients undergoing colorectal surgery for cancer.
    Holwell A; McKenzie JL; Holmes M; Woods R; Nandurkar H; Tam CS; Bazargan A
    ANZ J Surg; 2014 Apr; 84(4):284-8. PubMed ID: 23782713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer.
    Vedovati MC; Becattini C; Rondelli F; Boncompagni M; Camporese G; Balzarotti R; Mariani E; Flamini O; Pucciarelli S; Donini A; Agnelli G
    Ann Surg; 2014 Apr; 259(4):665-9. PubMed ID: 24253138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer.
    Tsutsumi S; Yajima R; Tabe Y; Takaaki T; Fujii F; Morita H; Kigure W; Kato T; Yamauchi H; Suto T; Asao T; Kuwano H
    Hepatogastroenterology; 2012; 59(120):2477-9. PubMed ID: 23169180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of dalteparin versus unfractionated heparin as venous thromboembolism prophylaxis in malignant gynecologic surgery.
    Wade WE; Spruill WJ
    Am J Ther; 2008; 15(6):512-5. PubMed ID: 19127133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study.
    Francis CW; Kessler CM; Goldhaber SZ; Kovacs MJ; Monreal M; Huisman MV; Bergqvist D; Turpie AG; Ortel TL; Spyropoulos AC; Pabinger I; Kakkar AK
    J Thromb Haemost; 2015 Jun; 13(6):1028-35. PubMed ID: 25827941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Venous thromboembolism prophylaxis after total hip arthroplasty].
    Kučera T; Malý R; Urban K; Sponer P
    Acta Chir Orthop Traumatol Cech; 2011; 78(2):101-5. PubMed ID: 21575551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of fondaparinux for prophylaxis of venous thromboembolism after colorectal cancer resection: a propensity score matched analysis.
    Yamaoka Y; Ikeda M; Ikenaga M; Haraguchi N; Miyake M; Sekimoto M
    Dig Surg; 2015; 32(3):190-5. PubMed ID: 25871913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
    Raskob G; Cohen AT; Eriksson BI; Puskas D; Shi M; Bocanegra T; Weitz JI
    Thromb Haemost; 2010 Sep; 104(3):642-9. PubMed ID: 20589317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.
    Eriksson BI; Arfwidsson AC; Frison L; Eriksson UG; Bylock A; Kälebo P; Fager G; Gustafsson D
    Thromb Haemost; 2002 Feb; 87(2):231-7. PubMed ID: 11858482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of extended postoperative venous thromboembolism prophylaxis in IBD: a National Surgical Quality Improvement Program analysis.
    Gross ME; Vogler SA; Mone MC; Sheng X; Sklow B
    Dis Colon Rectum; 2014 Apr; 57(4):482-9. PubMed ID: 24608305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing and perioperative risk factors for in-hospital and post-discharge venous thromboembolism after colorectal cancer resection.
    Davenport DL; Vargas HD; Kasten MW; Xenos ES
    Clin Appl Thromb Hemost; 2012 Nov; 18(6):569-75. PubMed ID: 22345485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prophylactic dalteparin on anti-factor Xa levels in morbidly obese patients after bariatric surgery.
    Simoneau MD; Vachon A; Picard F
    Obes Surg; 2010 Apr; 20(4):487-91. PubMed ID: 18931882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic Complications and Prophylaxis Patterns in Colorectal Surgery.
    ; Nelson DW; Simianu VV; Bastawrous AL; Billingham RP; Fichera A; Florence MG; Johnson EK; Johnson MG; Thirlby RC; Flum DR; Steele SR
    JAMA Surg; 2015 Aug; 150(8):712-20. PubMed ID: 26060977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is extended thromboprophylaxis necessary in elective colorectal cancer surgery?
    Chandra R; Melino G; Thomas M; Lawrence MJ; Hunter RA; Moore J
    ANZ J Surg; 2013 Dec; 83(12):968-72. PubMed ID: 23802729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.